Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
31 studies found for:    lectins
Show Display Options
Rank Status Study
1 Withdrawn Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia
Conditions: Fever, Sweats, and Hot Flashes;   Infection;   Leukemia;   Lymphoma;   Myelodysplastic Syndromes;   Neutropenia;   Unspecified Childhood Solid Tumor, Protocol Specific
Intervention: Biological: recombinant human mannose-binding lectin
2 Completed Study on Mannan Binding Lectin (MBL) Substitution in MBL-Deficient Children With Chemotherapy-Induced Neutropenia
Conditions: MBL-Deficient;   Neutropenia
Interventions: Drug: Mannan Binding Lectin (MBL);   Drug: Mannan Binding Lectin
3 Active, not recruiting The Complement Lectin Pathway After Cardiac Arrest
Conditions: Out-of-Hospital Cardiac Arrest;   Post Cardiac Arrest Syndrome
Intervention: Other: Targeted temperature management (33 degree Celsius)
4 Completed The Effect of Weight Loss on Serum Mannose-Binding Lectin(MBL) Levels
Conditions: Obesity;   Weight Loss
Intervention: Other: Weight loss
5 Completed Mistletoe Lectin in Treating Patients With Refractory Advanced Solid Tumors
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Dietary Supplement: mistletoe extract
6 Completed Mistletoe Lectin in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Dietary Supplement: mistletoe extract
7 Completed Association Between Deficiency of MBL (Mannose-Binding Lectin) and Polymorphisms in MBL2 Gene to Urinary Tract Infection
Condition: Recurrent Urinary Tract Infections
Intervention:
8 Completed Genetic Polymorphisms of Mannan-binding Lectin (MBL)and Serum Levels of MBL in Patients With Endometriosis
Condition: Endometriosis
Intervention:
9 Completed Study of the Level of a Protein Which Could Predict the Development of a Fungal Infection in Patients With Acute Leukemia
Conditions: Acute Leukemia;   Invasive Fungal Infection
Intervention: Biological: blood sample
10 Withdrawn A Study of Safety, Tolerability, and Pk of rhMBL in Pediatric Hematology/Oncology Pts With Fever and Neutropenia
Conditions: Cancer;   Hematologic Diseases;   Fever;   Neutropenia
Intervention: Drug: Intravenous recombinant human mannose binding lectin
11 Recruiting Innate Immunity Gene Polymorphisms and Yeast Colonization
Condition: Critical Illness
Intervention:
12 Terminated A Multicenter Study Evaluating the Safety and Tolerability of Intravenous rhMBL in Liver Transplant Recipients.
Condition: Liver Transplantation
Intervention: Drug: Intravenous Recombinant Human Mannose-Binding Lectin (rhMBL)
13 Recruiting Lung and Systemic Inflammation in the Critically Ill Patient
Conditions: Acute Respiratory Distress Syndrome (ARDS);   Systemic Inflammatory Response Syndrome (SIRS);   Sepsis
Intervention:
14 Unknown  Immunological Interaction Between the Host and Candida Albicans Biofilm
Condition: Candidiasis
Intervention:
15 Completed Intravenous rhMBL in Patients With Multiple Myeloma Receiving Chemotherapy Followed by Stem Cell Transplant
Condition: Multiple Myeloma
Intervention: Drug: Intravenous Recombinant Human Mannose-Binding Lectin (rhMBL)
16 Recruiting Preventing Fucose-dependent Binding of Aspergillus and Pseudomonas to Lung Mucin
Condition: Cystic Fibrosis
Intervention:
17 Completed Determination of Genetic Polymorphisms in Chronic Chagas Cardiomyopathy
Condition: Chagas Disease
Intervention: Genetic: Gathering of samples of genetic material
18 Unknown  Study on Neutropenia Induced by Adjuvant Paclitaxel/Carboplatin Chemotherapy in Patients With Epithelial Ovarian Cancer
Condition: Epithelial Ovarian Cancer
Intervention:
19 Completed Effect of 15% Eflornithine Hydrochloride Cream on African-American Males With Pseudofolliculitis Barbae
Condition: Pseudofolliculitis Barbae
Intervention: Drug: 15% Eflornithine Hdyrochloride
20 Completed Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Cryptococcus Neoformans Infection in Patients Not Infected With HIV and Complications Associated With Cryptococcus Neoformans Infection
Condition: Cryptococcosis
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-31) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.